Ledger.Open graph →
SEC Form D · filed June 15, 2021

BriaCell Therapeutics Corp

Offering
$27.2M
Sold
$27.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WEST VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Martin Schmieg · West Vancouver, British Columbia, CanadaDirectorWilliam Williams · West Vancouver, British Columbia, CanadaExec · DirectorGadi Levin · Caesarea Industrial Park, L3ExecJamieson Bondarenko · West Vancouver, British Columbia, CanadaExec · DirectorRebecca Taub · Fort Washington, PADirectorVaughn Embro-Pantalony · MISSISSAUGA, Ontario, CanadaDirectorGadi Levin · Caesarea Industrial Park, L3ExecMartin Schmieg · West Vancouver, British Columbia, CanadaDirectorWilliam Williams · West Vancouver, British Columbia, CanadaExec · DirectorJamieson Bondarenko · West Vancouver, British Columbia, CanadaExec · DirectorRebecca Taub · Fort Washington, PADirectorVaughn Embro-Pantalony · MISSISSAUGA, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗